Liaoning Kelong Fine ChemicalInc Past Earnings Performance
Past criteria checks 0/6
Liaoning Kelong Fine ChemicalInc's earnings have been declining at an average annual rate of -32.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 11.1% per year.
Key information
-32.6%
Earnings growth rate
-33.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -11.1% |
| Return on equity | -19.7% |
| Net Margin | -16.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Subdued Growth No Barrier To Liaoning Kelong Fine Chemical,Inc. (SZSE:300405) With Shares Advancing 26%
Sep 30
Liaoning Kelong Fine Chemical,Inc. (SZSE:300405) May Have Run Too Fast Too Soon With Recent 34% Price Plummet
Apr 16Liaoning Kelong Fine Chemical,Inc.'s (SZSE:300405) 33% Share Price Plunge Could Signal Some Risk
Feb 26Revenue & Expenses Breakdown
How Liaoning Kelong Fine ChemicalInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 602 | -97 | 88 | 10 |
| 30 Jun 24 | 579 | -104 | 93 | 10 |
| 31 Mar 24 | 549 | -103 | 87 | 10 |
| 31 Dec 23 | 558 | -100 | 91 | 9 |
| 30 Sep 23 | 520 | -111 | 106 | 12 |
| 30 Jun 23 | 715 | -140 | 114 | 11 |
| 31 Mar 23 | 754 | -123 | 126 | 11 |
| 01 Jan 23 | 780 | -119 | 131 | 13 |
| 30 Sep 22 | 946 | -28 | 100 | 11 |
| 30 Jun 22 | 991 | 12 | 98 | 12 |
| 31 Mar 22 | 1,083 | 11 | 100 | 13 |
| 01 Jan 22 | 1,089 | 12 | 94 | 11 |
| 30 Sep 21 | 1,055 | -69 | 90 | 19 |
| 30 Jun 21 | 953 | -42 | 92 | 20 |
| 31 Mar 21 | 993 | -50 | 103 | 22 |
| 31 Dec 20 | 929 | -61 | 112 | 22 |
| 30 Sep 20 | 989 | 17 | 107 | 18 |
| 30 Jun 20 | 990 | -11 | 115 | 15 |
| 31 Mar 20 | 863 | -9 | 109 | 13 |
| 31 Dec 19 | 944 | 11 | 113 | 13 |
| 30 Sep 19 | 970 | -101 | 141 | 11 |
| 30 Jun 19 | 1,055 | -94 | 145 | 11 |
| 31 Mar 19 | 1,188 | -95 | 147 | 12 |
| 31 Dec 18 | 1,195 | -100 | 144 | 12 |
| 30 Sep 18 | 1,219 | 15 | 131 | 15 |
| 30 Jun 18 | 1,200 | 14 | 116 | 30 |
| 31 Mar 18 | 1,180 | 23 | 109 | 27 |
| 31 Dec 17 | 1,127 | 23 | 116 | 26 |
| 30 Sep 17 | 1,060 | 28 | 115 | 17 |
| 30 Jun 17 | 928 | 26 | 114 | 0 |
| 31 Mar 17 | 787 | 16 | 105 | 0 |
| 31 Dec 16 | 777 | 16 | 91 | 0 |
| 30 Sep 16 | 698 | -18 | 100 | 0 |
| 30 Jun 16 | 712 | -26 | 96 | 0 |
| 31 Mar 16 | 778 | -24 | 105 | 0 |
| 31 Dec 15 | 800 | -29 | 107 | 0 |
| 30 Sep 15 | 893 | -7 | 87 | 0 |
| 30 Jun 15 | 936 | 8 | 82 | 0 |
| 31 Mar 15 | 1,056 | 26 | 83 | 0 |
| 31 Dec 14 | 1,137 | 38 | 85 | 0 |
| 31 Dec 13 | 1,004 | 53 | 78 | 0 |
Quality Earnings: 300405 is currently unprofitable.
Growing Profit Margin: 300405 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300405 is unprofitable, and losses have increased over the past 5 years at a rate of 32.6% per year.
Accelerating Growth: Unable to compare 300405's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300405 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 300405 has a negative Return on Equity (-19.72%), as it is currently unprofitable.